Darma Henwa Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Darma Henwa Tbk trades at Rp366 (market cap 14.73T, 270.15M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 42.8K 24h volume). The key difference: Darma Henwa Tbk is far larger — about 88× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Darma Henwa Tbk is more actively traded (270.15M versus 42.8K). Which is the better fit depends on your goals.
| DEWA | OBAT | |
|---|---|---|
Market Cap | 14.73T | 167.37B |
Volume | 270.15M | 42.8K |
Lot | 2.7M | 428 |
Turnover | 97.92B | 10.55M |
Average Price | 362.48 | 246.48 |
Value | 97.92B | 10.55M |
Indicative Equilibrium Price | 362 | 246 |
Indicative Equilibrium Volume | 1.86M | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
Darma Henwa Tbk (the Company) was established on 8 Oct 1991 based on Notaries Deed No.54, then changed to PT HWE Indonesia on Jan 2005. The Company started its commercial operations on 1993 with early main bussines in mining, and machine and equipment leasing. At Sep 5, 2005 company's name changed to PT Darma Henwa.
Read more on DEWA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →